Hepatitis C Testing Market Research Report 2022: Size, Segments, Share, Trends, Analysis, Regulatory & Reimbursement Landscape, Proceedings & Forecast, 2015-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hepatitis C Testing Market Size (Value, Volume, ASP) by Segments, Share, Trend & SWOT Analysis, Regulatory & Reimbursement Landscape, Proceedings & Forecast, 2015-2030” report has been added to from ResearchAndMarkets.com offer.

The model examines in detail the impact of COVID-19 on the Hepatitis C Testing market for the year 2020 and beyond.

Hepatitis C is a viral infection caused by the hepatitis C virus (HCV). Hepatitis C virus is a bloodborne virus that causes liver disease and can cause acute and chronic hepatitis. Infection can be caused by injection drug use, transfusion of uncontrolled blood products, unsafe injection practices, sexual contact, and from the infected mother to her baby.

Diagnosis of HCV infection can be made by screening for anti-HCV antibodies as well as a serological test to confirm viral infection. Nucleic acid testing for HCV ribonucleic acid (RNA) is done in case of positive test results for anti-HCV antibodies to confirm chronic infection.

Since there is no available vaccine against HCV infection, the World Health Organization (WHO) recommends blood tests to screen for patients who are at increased risk of HCV infection and reduce the risk exposure to HCV in health care settings. HCV screening of pregnant women is the standard of care in most countries and is considered a cost-effective strategy to reduce the risk of transmission to the baby.

Tests for hepatitis C virus include hepatitis C enzyme immunoassay/enzyme immunoassay (EIA/ELISA), hepatitis C nucleic acid amplification test (NAAT ) and multiparameter nucleic acid amplification tests for HIV, hepatitis B and hepatitis C (NAAT). ).

Each of the color-coded, fully-sourced market models from the 39 countries covered is equipped with epidemiology-based indications with procedure volumes. To increase data transparency, interactive Excel deliverable covers installed base, new sales volumes, product usage, average sales prices, market size and company share/rank analysis (if applicable). Additionally, analyst commentary with qualitative insight provides context for quantitative data.

Reasons to buy

  • To understand the impact of COVID-19 on the Hepatitis C Testing Market.

  • Develop and design your licensing and out-licensing strategies through a review of pipeline products and technologies, and identifying the companies with the strongest pipeline.

  • Develop business strategies by understanding the trends shaping and driving the Hepatitis C Testing market.

  • Generate revenue by understanding the key trends, innovative products and technologies, market segments, and companies that are likely to impact the Hepatitis C Testing market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the company’s share among market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.

  • Track device sales in the global and country-specific hepatitis C testing market from 2015 to 2030.

  • Organize your sales and marketing efforts by identifying the categories and market segments that present the maximum opportunities for consolidations, investments and strategic partnerships.

The main inclusions of the market model are:

  • Currently Marketed Hepatitis C Tests and the Evolving Competitive Landscape

  • Insightful review of key industry trends.

  • Total annualized revenue of Hepatitis C testing market by segment and market outlook from 2015 to 2030.

  • Market level data on units, average selling prices and market values.

Global, regional and country specific market information:

  • Market-specific qualitative information is available with global trends broken down into regional trends. Additionally, analysts provide unique market insights specific to each country.

  • SWOT analysis for Hepatitis C Testing Market.

  • Provided competitive dynamics insights and trends for the Hepatitis C Testing Market.

Improve understanding of the market by getting a true overview, including insight into the healthcare system.

  • Overview of the health system by country.

  • Country specific refund policies.

  • Country-specific medical technology regulatory landscape.

Companies covered:

  • Abbott Laboratories

  • Siemens AG

  • Grifols SA

  • F. Hoffmann-La Roche SA

  • Ortho Clinical Diagnostics Holdings Plc

  • Hologic Inc.

  • Oswaldo Cruz Foundation

  • Grifols SA

  • Qiagen AG

  • DiaSorin SpA

For more information on this report, visit https://www.researchandmarkets.com/r/nbke3l

Comments are closed.